Kaiser Permanente researchers have developed a new risk score that clinicians can use to identify type 2 diabetes patients who are at risk for dementia, according to a study in The Lancet Diabetes and Endocrinology. To determine the score, researchers examined information from two longitudinal cohorts of patients ages 60 and older who had 10 or more years of follow-up recorded in the Kaiser Permanente Northern California Diabetes Registry. The risk score is based on factors such as age, education, diabetic foot disease, acute metabolic events and cerebrovascular and cardiovascular disease.

Related Summaries